1. Home
  2. EPM vs ACHV Comparison

EPM vs ACHV Comparison

Compare EPM & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$3.52

Market Cap

133.7M

Sector

Energy

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$7.55

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
ACHV
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.7M
726.5M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EPM
ACHV
Price
$3.52
$7.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.83
★ $14.67
AVG Volume (30 Days)
538.5K
★ 1.4M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
★ 10.08%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $43,229,621.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$2.62
52 Week High
$5.03
$8.64

Technical Indicators

Market Signals
Indicator
EPM
ACHV
Relative Strength Index (RSI) 43.44 47.78
Support Level $3.48 $7.01
Resistance Level $3.82 $8.63
Average True Range (ATR) 0.16 0.39
MACD -0.01 -0.04
Stochastic Oscillator 9.17 37.94

Price Performance

Historical Comparison
EPM
ACHV

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: